Citius Pharmaceuticals, Inc. Operating Lease Liability
Citius Pharmaceuticals, Inc. (CTXR) had Operating Lease Liability of $766.96 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-14
- 2026-06-30: Operating Lease, Liability $766.96K.
- 2026-03-31: Operating Lease, Liability $808.16K.
- 2025-12-31: Operating Lease, Liability $829.65K.
- 2025-09-30: Operating Lease, Liability $813.27K.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $766.96K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $808.16K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $829.65K 10-Q · filed 2026-02-13 |
| 2025-09-30 | $813.27K 10-Q · filed 2026-08-14 |
| 2025-06-30 | $881.65K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $931.79K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $204.57K 10-Q · filed 2025-02-14 |
| 2024-09-30 | $262.87K 10-K · filed 2025-12-23 |
| 2024-06-30 | $320.01K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $374.83K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $428.57K 10-Q · filed 2024-02-14 |
| 2023-09-30 | $481.25K 10-K · filed 2024-12-27 |
| 2023-06-30 | $532.88K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $582.30K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $630.75K 10-Q · filed 2023-02-10 |
| 2022-09-30 | $678.23K 10-K · filed 2023-12-29 |
| 2022-06-30 | $724.78K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $769.22K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $812.77K 10-Q · filed 2022-02-10 |
| 2021-09-30 | $855.47K 10-K · filed 2022-12-22 |
| 2021-06-30 | $897.33K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $937.15K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $976.20K 10-Q · filed 2021-02-11 |
| 2020-09-30 | $1.01M 10-K · filed 2021-12-15 |
| 2020-06-30 | $1.05M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $1.09M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $1.12M 10-Q · filed 2020-02-13 |
| 2019-10-01 | $1.11M 10-Q · filed 2019-08-14 |
| 2019-09-30 | $1.14M 10-K · filed 2019-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |